09 July 2018

APPROACH in the news

Recently, Drs. Engelke and Roemer from the University of Erlangen were interviewed by “Pharma Fakten”, a large German online news platform for the pharmaceutical industry, to report on the background and current status of the APPROACH project.

Both researchers emphasized the importance of the APPROACH Consortium for identification of patients who will likely most benefit from disease modifying therapy. The multicenter setting and number of European partners involved is unique and a great opportunity for the advancement of osteoarthritis research. Please find the link to the full interview (in German) here.